Guselkumab is a medication being studied for its long-term safety in children with certain inflammatory conditions. It is used to help manage symptoms in pediatric patients who have moderately to severely active ulcerative colitis, Crohn’s disease, or juvenile psoriatic arthritis. The study aims to understand how safe this medication is for children over an extended period.

Juvenile Psoriatic Arthritis – This is a type of arthritis that affects children and is associated with psoriasis, a skin condition. It causes joint pain, swelling, and stiffness, often accompanied by patches of red, scaly skin. The disease can affect any joint and may lead to joint damage over time. Symptoms can vary in severity and may come and go, with periods of flare-ups and remission. It can also affect the nails and cause changes such as pitting or separation from the nail bed.

Moderately to Severely Active Ulcerative Colitis – This is a chronic inflammatory condition affecting the colon and rectum. It causes inflammation and ulcers in the lining of the large intestine, leading to symptoms like abdominal pain, diarrhea, and rectal bleeding. The disease often progresses with periods of exacerbation and remission. Over time, the inflammation can lead to complications such as strictures or increased risk of colon cancer. The exact cause is unknown, but it involves an abnormal immune response in the gut.

Moderately to Severely Active Crohn’s Disease – This is a chronic inflammatory bowel disease that can affect any part of the gastrointestinal tract, from the mouth to the anus. It causes inflammation that can penetrate deep into the layers of the bowel tissue, leading to symptoms such as abdominal pain, severe diarrhea, fatigue, and weight loss. The disease is characterized by periods of active symptoms and remission. Over time, it can lead to complications like strictures, fistulas, or malnutrition. The exact cause is not fully understood, but it involves an abnormal immune response.